Enfusion Q1 2024 Adj EPS $0.06 Beats $0.04 Estimate, Sales $48.052M Beat $47.616M Estimate
Enfusion Q1 2024 Adj EPS $0.06 Beats $0.04 Estimate, Sales $48.052M Beat $47.616M Estimate
Enfusion 2024年第一季度調整後每股收益0.06美元超過預期的0.04美元，銷售額4805.2萬美元超過4,7616萬美元的預期
Enfusion (NYSE:ENFN) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $0.04 by 50 percent. This is a 100 percent increase over earnings of $0.03 per share from the same period last year. The company reported quarterly sales of $48.052 million which beat the analyst consensus estimate of $47.616 million by 0.92 percent. This is a 17.28 percent increase over sales of $40.971 million the same period last year.
Enfusion（紐約證券交易所代碼：ENFN）公佈的季度收益爲每股0.06美元，比分析師共識估計的0.04美元高出50％。這比去年同期每股收益0.03美元增長了100％。該公司公佈的季度銷售額爲4,805.2萬美元，比分析師普遍預期的4,7616萬美元高出0.92％。這比去年同期的4,097.1萬美元的銷售額增長了17.28％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。